Impact BioMedical Inc. (IBO) News
Follow Impact BioMedical Inc. (IBO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
IBO - Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
IBO - Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
MNA | Sep 16, 2026, 01:20 PM UTC
H
Impact Biomedical approves 1-for-12.62 reverse stock split ahead of proposed Zoar merger
Impact Biomedical announced a 1-for-12.62 reverse stock split effective Sept. 23, 2026 to support its proposed merger with Zoar Limited and NYSE American continued-listing objectives.Key Highlights:Original SEC Filing: I
MNA | Sep 15, 2026, 10:13 AM UTC
H
IBO - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
IBO - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
MNA | Sep 15, 2026, 01:26 AM UTC
H
Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar
Impact Biomedical Inc AMEX:IBO
MNA | Sep 11, 2026, 08:21 PM UTC
H
Impact BioMedical Inc (NYSE American: IBO) Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar Ltd. (previously Dr. Ashley's Ltd.) >IBO
Impact BioMedical Inc (NYSE American: IBO) Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar Ltd. (previously Dr. Ashley's Ltd.) >IBO
MNA | Sep 11, 2026, 08:11 PM UTC